A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

NCT02598934 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Post Menopausal Osteoporosis

Interventions

DRUG: Ibandronate

Sponsor

Hoffmann-La Roche